vs

Side-by-side financial comparison of Privia Health Group, Inc. (PRVA) and Teladoc Health, Inc. (TDOC). Click either name above to swap in a different company.

Teladoc Health, Inc. is the larger business by last-quarter revenue ($642.3M vs $541.2M, roughly 1.2× Privia Health Group, Inc.). On growth, Privia Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 0.3%). Over the past eight quarters, Privia Health Group, Inc.'s revenue compounded faster (14.2% CAGR vs -0.3%).

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in New York, New York, United States that was founded in 2002. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.

PRVA vs TDOC — Head-to-Head

Bigger by revenue
TDOC
TDOC
1.2× larger
TDOC
$642.3M
$541.2M
PRVA
Growing faster (revenue YoY)
PRVA
PRVA
+17.1% gap
PRVA
17.4%
0.3%
TDOC
Faster 2-yr revenue CAGR
PRVA
PRVA
Annualised
PRVA
14.2%
-0.3%
TDOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRVA
PRVA
TDOC
TDOC
Revenue
$541.2M
$642.3M
Net Profit
$9.2M
Gross Margin
Operating Margin
2.1%
-5.6%
Net Margin
1.7%
Revenue YoY
17.4%
0.3%
Net Profit YoY
108.0%
EPS (diluted)
$0.08
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRVA
PRVA
TDOC
TDOC
Q4 25
$541.2M
$642.3M
Q3 25
$580.4M
$626.4M
Q2 25
$521.2M
$631.9M
Q1 25
$480.1M
$629.4M
Q4 24
$460.9M
$640.5M
Q3 24
$437.9M
$640.5M
Q2 24
$422.3M
$642.4M
Q1 24
$415.2M
$646.1M
Net Profit
PRVA
PRVA
TDOC
TDOC
Q4 25
$9.2M
Q3 25
$6.9M
$-49.5M
Q2 25
$2.7M
$-32.7M
Q1 25
$4.2M
$-93.0M
Q4 24
$4.4M
Q3 24
$3.5M
$-33.3M
Q2 24
$3.5M
$-837.7M
Q1 24
$3.0M
$-81.9M
Operating Margin
PRVA
PRVA
TDOC
TDOC
Q4 25
2.1%
-5.6%
Q3 25
2.5%
-8.3%
Q2 25
0.6%
-8.6%
Q1 25
1.1%
-19.2%
Q4 24
1.1%
-7.5%
Q3 24
1.3%
-6.9%
Q2 24
1.2%
-130.9%
Q1 24
0.2%
-13.5%
Net Margin
PRVA
PRVA
TDOC
TDOC
Q4 25
1.7%
Q3 25
1.2%
-7.9%
Q2 25
0.5%
-5.2%
Q1 25
0.9%
-14.8%
Q4 24
1.0%
Q3 24
0.8%
-5.2%
Q2 24
0.8%
-130.4%
Q1 24
0.7%
-12.7%
EPS (diluted)
PRVA
PRVA
TDOC
TDOC
Q4 25
$0.08
$-0.14
Q3 25
$0.05
$-0.28
Q2 25
$0.02
$-0.19
Q1 25
$0.03
$-0.53
Q4 24
$0.03
$-0.27
Q3 24
$0.03
$-0.19
Q2 24
$0.03
$-4.92
Q1 24
$0.02
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRVA
PRVA
TDOC
TDOC
Cash + ST InvestmentsLiquidity on hand
$479.7M
$781.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$737.2M
$1.4B
Total Assets
$1.4B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRVA
PRVA
TDOC
TDOC
Q4 25
$479.7M
$781.1M
Q3 25
$441.4M
$726.2M
Q2 25
$390.1M
$679.6M
Q1 25
$469.3M
$1.2B
Q4 24
$491.1M
$1.3B
Q3 24
$422.0M
$1.2B
Q2 24
$387.4M
$1.2B
Q1 24
$351.1M
$1.1B
Stockholders' Equity
PRVA
PRVA
TDOC
TDOC
Q4 25
$737.2M
$1.4B
Q3 25
$709.1M
$1.4B
Q2 25
$682.9M
$1.4B
Q1 25
$659.4M
$1.4B
Q4 24
$635.2M
$1.5B
Q3 24
$614.9M
$1.5B
Q2 24
$595.4M
$1.5B
Q1 24
$576.8M
$2.3B
Total Assets
PRVA
PRVA
TDOC
TDOC
Q4 25
$1.4B
$2.9B
Q3 25
$1.4B
$2.9B
Q2 25
$1.3B
$2.9B
Q1 25
$1.2B
$3.4B
Q4 24
$1.1B
$3.5B
Q3 24
$1.1B
$3.5B
Q2 24
$1.1B
$3.5B
Q1 24
$1.0B
$4.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRVA
PRVA
TDOC
TDOC
Operating Cash FlowLast quarter
$127.5M
$87.7M
Free Cash FlowOCF − Capex
$85.1M
FCF MarginFCF / Revenue
13.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
13.93×
TTM Free Cash FlowTrailing 4 quarters
$285.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRVA
PRVA
TDOC
TDOC
Q4 25
$127.5M
$87.7M
Q3 25
$52.0M
$99.3M
Q2 25
$8.0M
$91.4M
Q1 25
$-24.1M
$15.9M
Q4 24
$74.8M
$85.9M
Q3 24
$33.2M
$110.2M
Q2 24
$34.5M
$88.7M
Q1 24
$-33.1M
$8.9M
Free Cash Flow
PRVA
PRVA
TDOC
TDOC
Q4 25
$85.1M
Q3 25
$97.0M
Q2 25
$90.2M
Q1 25
$13.2M
Q4 24
$79.8M
Q3 24
$108.6M
Q2 24
$86.8M
Q1 24
$7.8M
FCF Margin
PRVA
PRVA
TDOC
TDOC
Q4 25
13.3%
Q3 25
15.5%
Q2 25
14.3%
Q1 25
2.1%
Q4 24
12.5%
Q3 24
17.0%
Q2 24
13.5%
Q1 24
1.2%
Capex Intensity
PRVA
PRVA
TDOC
TDOC
Q4 25
0.4%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
0.4%
Q4 24
1.0%
Q3 24
0.2%
Q2 24
0.3%
Q1 24
0.2%
Cash Conversion
PRVA
PRVA
TDOC
TDOC
Q4 25
13.93×
Q3 25
7.58×
Q2 25
2.97×
Q1 25
-5.70×
Q4 24
17.00×
Q3 24
9.38×
Q2 24
9.94×
Q1 24
-11.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRVA
PRVA

FFS Patient Care$364.4M67%
Capitated Revenue$71.4M13%
Shared Savings$46.9M9%
FFS Administrative Services$36.0M7%
Care Management Fee PMPM$20.0M4%
Other Revenue$2.5M0%

TDOC
TDOC

Teladoc Health Integrated Care$409.1M64%
Better Help$233.2M36%

Related Comparisons